Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

730 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Stimulated parametric emission microscopy.
Isobe K, Kataoka S, Murase R, Watanabe W, Higashi T, Kawakami S, Matsunaga S, Fukui K, Itoh K. Isobe K, et al. Among authors: kataoka s. Opt Express. 2006 Jan 23;14(2):786-93. doi: 10.1364/opex.14.000786. Opt Express. 2006. PMID: 19503398 Free article.
Histone H2A mobility is regulated by its tails and acetylation of core histone tails.
Higashi T, Matsunaga S, Isobe K, Morimoto A, Shimada T, Kataoka S, Watanabe W, Uchiyama S, Itoh K, Fukui K. Higashi T, et al. Among authors: kataoka s. Biochem Biophys Res Commun. 2007 Jun 8;357(3):627-32. doi: 10.1016/j.bbrc.2007.03.203. Epub 2007 Apr 10. Biochem Biophys Res Commun. 2007. PMID: 17445770
Building Better Bridges: Outcomes of a Community-Partnered New School Transition Intervention for Students on the Autism Spectrum.
Nuske HJ, Smith T, Levato L, Bronstein B, Sparapani N, Garcia C, Castellon F, Lee HS, Vejnoska SF, Hochheimer S, Fitzgerald AR, Chiappe JC, Nunnally AD, Li J, Shih W, Brown A, Cullen M, Hund LM, Stahmer AC, Iadarola S, Mandell DS, Hassrick EM, Kataoka S, Kasari C. Nuske HJ, et al. Among authors: kataoka s. J Autism Dev Disord. 2024 Jun 12. doi: 10.1007/s10803-024-06285-7. Online ahead of print. J Autism Dev Disord. 2024. PMID: 38865033
Safety/efficacy of atezolizumab + bevacizumab during anti-platelet/anticoagulation therapy in unresectable hepatocellular carcinoma.
Moriguchi M, Okuda K, Horiguchi G, Kataoka S, Seko Y, Yamaguchi K, Nishimura T, Fujii H, Mitsumoto Y, Miyagawa M, Kirishima T, Okishio S, Hara T, Ishikawa H, Nagao Y, Jo M, Ishii M, Tanaka S, Yamauchi N, Mitsuyoshi H, Nakajima T, Taketani H, Yano K, Arai M, Umemura A, Itoh Y. Moriguchi M, et al. Among authors: kataoka s. Liver Int. 2024 Jun 4. doi: 10.1111/liv.15918. Online ahead of print. Liver Int. 2024. PMID: 38838097
730 results